The long-acting Respiratory Syncytial Virus (RSV) immunisation is now available free for eligible families until September 30. Premier Jacinta Allan and Minister for Children Lizzie Blandthorn opened ...

A LARGE international trial has found that a single dose of the RSVPreF3 OA vaccine offers strong and sustained protection against respiratory syncytial virus (RSV)-related lower respiratory tract ...

Respiratory virus data included in the interactive data application is up-to-date as of April 26, 2025. Among its new features, the dashboard now includes RSV Severe Outcomes data.

Pfizer Inc. announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory ...

Future Virology. 2014;9(8):753-767. CHF: Congestive heart failure; CLD: Chronic lung disease; F: Fusion; G: Glyco; GLA-SE: Glucopyranosyl lipid A-stable emulsion; GMT ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has issued new separate recommendations supporting expanded use of Pfizer’s respiratory syncytial ...

Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a panel of experts advising the Centers for Disease Control and ...

The US Advisory Committee on Immunization Practices (ACIP) has voted to recommend the use of respiratory syncytial virus (RSV) vaccines, including GSK's adjuvanted Arexvy, for use in the adult ...

The updated recommendation calls for a single vaccine dose for adults ages 50-59 with underlying medical conditions who are at increased risk for severe RSV illness. The CDC’s existing RSV ...